AASLD guidelines for treatment of chronic hepatitis B

Hepatology. 2016 Jan;63(1):261-83. doi: 10.1002/hep.28156. Epub 2015 Nov 13.

Authors

Norah A Terrault¹, Natalie H Bzowej², Kyong-Mi Chang³, Jessica P Hwang⁴, Maureen M Jonas⁵, M Hassan Murad⁶; American Association for the Study of Liver Diseases

Affiliations

¹ University of California San Francisco, San Francisco, CA.
² Ochsner Medical Center, New Orleans, LA.
³ Corporal Michael J. Crescenz VA Medical Center & University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.
⁴ The University of Texas MD Anderson Cancer Center, Houston, TX.
⁵ Boston Children's Hospital, Harvard Medical School, Boston, MA.
⁶ Mayo Clinic, Rochester, MN.

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Antiviral Agents / therapeutic use*
Hepatitis B Antigens / blood
Hepatitis B, Chronic / blood
Hepatitis B, Chronic / complications
Hepatitis B, Chronic / diagnosis
Hepatitis B, Chronic / drug therapy*
Hepatitis B, Chronic / immunology
Humans
Viremia / virology

Substances

Antiviral Agents
Hepatitis B Antigens

Grants and funding

P30 CA016672/CA/NCI NIH HHS/United States